Biolife Solutions (BLFS) Operating Leases (2019 - 2026)

Biolife Solutions (BLFS) has 8 years of Operating Leases data on file, last reported at $12.4 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $12.4 million, down 11.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.4 million (down 11.73% YoY), and the FY2025 annual result was $10.7 million, down 15.72% from the prior year.
• Operating Leases improved to $12.4 million in Q1 2026 per BLFS's latest filing, from $10.7 million in the prior quarter.
• Over five years, Operating Leases peaked at $18.7 million in Q1 2022 and troughed at $8.7 million in Q4 2023.
• A 5-year average of $14.2 million and a median of $14.0 million in 2025 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2022 and 2023: Operating Leases soared 101.23% in 2022, then slumped 41.89% in 2023.
• A 5-year view of Operating Leases shows it stood at $15.0 million in 2022, then sank by 41.89% to $8.7 million in 2023, then soared by 45.43% to $12.6 million in 2024, then decreased by 15.72% to $10.7 million in 2025, then increased by 15.96% to $12.4 million in 2026.
• Business Quant data shows BLFS's Operating Leases at $12.4 million in Q1 2026, $10.7 million in Q4 2025, and $13.2 million in Q3 2025.